TD Cowen Upgrades Vertiv Price Target on Data Center Demand Outlook Legal IP Challenges in Smart Manufacturing Data Ownership Trade Secrets and AI Patent Trends Trump Pledges to Protect Crypto Industry and Ensure Prediction Markets Thrive Report Reveals Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil Prices Higher This Summer EU and Mexico Seal Updated Trade Deal to Diversify Supply Chains Amid Global Tensions Jim Cramers Morning Meeting Highlights Market Opportunities and Risks MBRX Q1 2026 Earnings EPS Misses Estimates as Development Costs Rise HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue Pentair Q1 2026 Earnings EPS Beats Estimates by 329 YOU Q1 2026 Earnings EPS Beats Estimates by 12 but Stock Declines Despite Profit Surprise MUFG Q1 2026 Earnings Strong EPS Surprise of 397 Despite Stock Dip PGEN Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Sizzle Acquisition Corp II SZZL Holds Steady at 1032 Amidst SPAC Market Dynamics Newbridge Acquisition Unit NBRGU Holds Steady Near Support as Technicals Suggest Consolidation Equillium Inc EQ Gains Ground as Stock Edges Past Key Support Level T Rowe Price Group Inc TROW Edges Higher as Shares Test Resistance Amentum Holdings AMTM Surges 316 as Stock Approaches Key Resistance Level Why Most US Manufacturers Still Arent Using AI and Automation Analysis Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Tectonic Therapeutic TECX Slides 174 as Biotech Sector Headwinds Persist ZBRA Q1 2026 Earnings Earnings Beat Drives Stock Higher Eagle Bancorp Montana Inc EBMT Q1 2026 Earnings EPS Beat Boosts Investor Sentiment NVGS Q1 2026 Earnings EPS Surges Past Estimates Despite Negative Market Reaction PRH Q1 2026 Earnings EPS Surges 154 Above Estimates Positive Market Response PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Beat Driven by Investment Portfolio Stock Remains Flat NVAX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Edges Higher GHRS Q1 2026 Earnings WiderthanExpected Loss Underscores ClinicalStage Challenges